It has been shown that patients with type 2 diabetes have an increased risk of developing breast cancer [46], that high glucose induces microtubule hyperacetylation in cultured schwannoma cells [47], and that hyperacetylation of microtubules, possibly through the inhibition of Sirt2, occurs in the tissues of an animal model of diabetes [48]. This evidence concerns the gene SIRT2 and breast cancer.